INGREZZA and INGREZZA SPRINKLE are indicated for the treatment of adults with:<br>- tardive dyskinesia [see Clinical Studies ( 14.1 )] .<br>- chorea associated with Huntington’s disease [see Clinical Studies ( 14.2 )] .<br>INGREZZA and INGREZZA SPRINKLE are vesicular monoamine transporter 2 (VMAT2) inhibitors indicated for the treatment of adults with: - tardive dyskinesia. ( 1 ) - chorea associated with Huntington’s disease. ( 1 )<br><content styleCode="bold">1 </content><br>                      <br>    <content styleCode="bold">INDICATIONS AND USAGE</content><br>                   <br>  INGREZZA and INGREZZA SPRINKLE are indicated for the treatment of adults with: - tardive dyskinesia [see Clinical Studies ( 14.1 )] . - chorea associated with Huntington’s disease [see Clinical Studies ( 14.2 )] . INGREZZA and INGREZZA SPRINKLE are vesicular monoamine transporter 2 (VMAT2) inhibitors indicated for the treatment of adults with: - tardive dyskinesia. ( 1 ) - chorea associated with Huntington’s disease. ( 1 )